Publications-Presentations-Grants:
PUBLICATIONS:
1. Scalable robotic biofabrication of tissue spheroids. Mehesz AN, Brown J,
Hajdu Z, Beaver W, da Silva JV, Visconti RP, Markwald RR, Mironov V.
Biofabrication. 2011 Jun;3(2):025002. Epub 2011 May 12.
2. Fleming, PA, Argraves WS, Gentile C, Neagu A, Forgacs G, Drake CJ. Fusion of
uniluminal vascular spheroids: A model for assembly of blood vessels. Dev
Dyn. 2010; 239: 398–406.
3. Hajdu Z, Mironov V, Mehesz AN, Norris RA, Markwald RR, Visconti RP.
Tissue spheroid fusion-based in vitro screening assays for analysis of tissue
maturation J Tissue Eng Regen Med. 2010 Dec;4(8):659-64.
4. Gentile, C, Fleming, PA, Mironov, V, Argraves, KM, Argraves, WS, Drake, CJ.
VEGF-mediated fusion in the generation of uniluminal vascular spheroids.
Dev Dyn. 2008; 237(10): 2918-25.
5. Mironov, V, Visconti, RP, Kasyanov, V, Forgacs, G, Drake, CJ, Markwald, RR.
(2009). Organ printing: tissue spheroids as building blocks. Biomaterials.
2009;30(12):2164-2174.
6. Mironov V, Kasyanov V, Drake CJ, Markwald RR. Organ printing: promises
and challenges. Regen Med. 2008; 3(1): 93-103.
7. Hajdu Z, Romeo, SJ, Fleming, PA, Markwald, RR, Visconti, RP, Drake, CJ.
(2011) Recruitment of bone marrow-derived valve interstitial cells is a
normal homeostatic process. J Mol Cell Cardiol 51(6): 955-65.
8. Tourkina, E, Bonner, M, Oates, J, Hofbauer, A, Richard, M, Znoyko, S, Visconti,
RP, Zhnag, J, Hatfield, CM, Silver, RM, Hoffman, S. (2011) Altered monocyte
and fibrocyte phenotype and function in scleroderma interstitial lung
disease: reversal by caveolin-1 scaffolding domain peptide. Fibro Tissue
Repair 4(1):15.
PRESENTATIONS AND POSTERS:
1. International Congress on Biohydrogels Viareggio, Italy. A Bioprocessible Biomimetic Hydrogel for the Optimal Fusion of Vascular Tissue Spheroids.
2. Third World Congress on Regenerative Medicine Leipzig, Germany.
Bioengineering Lumenized Blood Vessel-like Tissue Spheroids from Adult
Human Cells.
3. Cambridge Healthtech Institute’s Third Annual CELLutions Summit,
Cambridge, MA. Generation of a Three Dimensional Vascular Micro-Tissue as
Module for the Assembly of Blood Vessels.
4. Experimental Biology San Diego, CA. Blood Vessel-Like Tissue Spheroids as
Modules for the Assembly of Blood Vessels.
5. Annual TERMIS-NA Toronto, Canada. Engineering of human Blood VesselLike Tissue Spheroids: Building blocks for blood vessels.
6. Engineering Tissues - Replace Repair Regenerate Hilton Head Workshop.
Bioengineering Lumenized Blood Vessel-like Structures from Tissue
Spheroids.
GRANTS FUNDED:
1. MUSC Provost Award to Advance Bioengineering (Drake PI): Analysis of
influence of flow on the biophysical properties of uniluminal vascular
spheroids and linear vascular structures (04/01/11–05/31/12).
2. NSF EPSCoR RII GEAR, EPS-0903795 Task No. 0052 (Drake PI): A Modular
Approach for Engineering of a Self-Assembling Vascular Tree Using
Prefabricated Vascular Elements as Building Blocks (09/01/09–6/30/10).
3. NSF EPSCoR RII GEAR, EPS-0903795 Task No. 0052 (Visconti PI): Adipose
as a source for generation of vascular smooth muscle for vessel
biofabrication. (09/01/10–6/30/11).
4. 1R01NIAMS (Visconti Co-PI) Control of monocyte and fibrocyte phenotype
in scleroderma lung fibrotic disease by caveolin-1 (07/01/201206/30/2017).
GRANTS NOT FUNDED:
1. 1RC1EB010720-01 (C. Drake PI; S. Argraves Co-PI) Engineering Vascular
Networks Using Self-Assembling Prefabricated Elements (11/10/11).
2. 1R21HL108673-01 (C. Drake PI; S. Argraves Co-PI): Vascular Spheroids:
Blood Vessel Building Blocks for Tissue Engineering. (06/16/2011).
3. AHA (Visconti, Co-PI) Janus spheroids for vascular bioassembly.
(07/01/2011).
4. 1R01NIAMS (Visconti, Co-PI) Role of Akt3 in dermal wound healing.
(10/5/2011).
5. 1R01NHLBI (Visconti, Co-I) A role for the HOX gene code in postnatal
vascular cell specification. (11/05/2011).
6. DOD-DARPA (Visconti Co-PI) Perfusable microtissue assemblies to screen
for drug toxicity. (12/15/2011).
GRANTS PENDING:
1. 1R15NHLBI (Visconti, Co-PI) Janus spheroids for vascular bioassembly
(10/05/2011).
2. 1R01NIBIB (Visconti, Co-PI) Engineering pre-vascularized biomimetic
matrices for bone regeneration (10/05/2011).
3. 1R21NHLBI (Visconti, Co-PI) Role of sphingolipids in atherogenic plaque
formation (11/05/2011).
4. 1R01NINDS (Visconti Co-PI) Perfusable microtissue assemblies to screen for
drug toxicity. (01/21/2012).
5. AHA-GIA (Visconti Co-PI) Janus spheroids for vascular bioassembly
(01/21/2012).
6. 1R01NHLBI (Visconti Co-PI) Developmental mechanisms of valve tissue
assembly and disease pathogenesis (02/05/2012).